Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
JAK2 inhibitor AZD1480 inhibits JAK2 activation
74 with vehicle) at high glucose concentration (12
2ClH/c14-5-7-17(20
disrupts its interaction with the transcription factor CBFβ
respectively) as well as CYP3A4 metabolism of 7-benzyloxy-4-trifluoromethylcoumarin (BFC) and dibenzylfluorescein (DBF
Emavusertib - CAS# 1801344-14-8 ericin B JAK2 inhibitor AZD1480 inhibits JAK2Emavusertib, also known as CA 4948 is a potent IRAK4 FLT3 inhibitor with anti tumor activity. CA 4948 demonstrated good cellular activity in ABC DLBCL and AML cell lines. CA 4948 demonstrated moderate to high selectivity in a panel of 329 kinases as well as exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with
US$ 35.00
US$ 10.00
US$ 13.50
US$ 13.50
US$ 13.50